Seroprevalence of human T-cell leukemia/lymphoma virus type I and type II (HTLV-I/HTLV-II) infection among volunteer blood donors in Kuwait

被引:7
|
作者
Al-Mufti, S [1 ]
Voevodin, A [1 ]
Ahmed, S [1 ]
Al Hamdan, S [1 ]
Al-Basheer, AA [1 ]
机构
[1] Minist Hlth, Publ Hlth Labs, Shaab 36057, Kuwait
关键词
human T-cell leukemia/lymphoma virus type I blood donors; antibodies; Western blot; Kuwait; Iran; India;
D O I
10.1159/000026068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The human T-cell leukemia/lymphoma virus type I (HTLV-I) is an etiologic agent of adult T-cell leukemia/lymphoma and tropical spastic paraparesis. One of the major routes of transmission of the virus is through blood transfusion. The aim of this study was to determine the prevalence of HTLV-I infection in volunteer blood donors in Kuwait. Methods: A donation of 97,602 blood units in Kuwait from March 1995 to October 1997 was tested for antibodies against HTLV-I and related virus (HTLV-II). The testing was carried out in three steps: first screening by enzyme immunoassay (EIA) for anti-HTLV-I/II, second testing of initially positive samples by the EIA and final confirmation of true positives by Western blot. Results: Twenty-one HTLV-l-positive donors have been identified (7 Kuwaitis, 5 Indians, 4 Iranians, 2 Bedouins, 1 Omani, 1 Egyptian and 1 Filipino). None of the EIA-reactive samples was positive for HTLV-II by Western blot. The frequency of HTLV-l-positive blood donations was: 1:4,648 and the infection was significantly more prevalent among Indians and Iranians. Conclusion: The prevalence of HTLV-I infection in blood donors in Kuwait is one of the highest in the world and compulsory screening of blood for HTLV-I is fully justified.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 50 条
  • [31] Mortality in a cohort of HTLV-I and HTLV-II infected blood donors.
    Orland, JR
    Wang, B
    Nass, C
    Garratty, G
    Smith, JW
    Newman, B
    Smith, D
    Loughlin, K
    Murphy, EL
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 : S8 - S8
  • [32] HTLV-I AND HTLV-II INFECTION IN US BLOOD-DONORS - 1989-1993
    SULLIVAN, MT
    WILLIAMS, AE
    FANG, CT
    NOTARI, EP
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 489 - 489
  • [33] High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies
    Mine, H
    Kawai, H
    Yokoi, K
    Akaike, M
    Saito, S
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1996, 74 (08): : 471 - 477
  • [34] SENSITIVE AND SPECIFIC POLYMERASE CHAIN-REACTION ASSAYS FOR DIAGNOSIS OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) AND HTLV-II INFECTIONS IN HTLV-I/II-SEROPOSITIVE INDIVIDUALS
    HENEINE, W
    KHABBAZ, RF
    LAL, RB
    KAPLAN, JE
    JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (06) : 1605 - 1607
  • [35] THE ROLE OF HUMAN T-CELL LYMPHOTROPIC VIRUSES (HTLV-I AND HTLV-II) IN CUTANEOUS T-CELL LYMPHOMAS
    ZUCKERFRANKLIN, D
    PANCAKE, BA
    SEMINARS IN DERMATOLOGY, 1994, 13 (03): : 160 - 165
  • [36] TYPE-SPECIFIC ANTIGENS FOR SEROLOGICAL DISCRIMINATION OF HTLV-I AND HTLV-II INFECTION
    CHEN, YMA
    LEE, TH
    WIKTOR, SZ
    SHAW, GM
    MURPHY, EL
    BLATTNER, WA
    ESSEX, M
    LANCET, 1990, 336 (8724): : 1153 - 1155
  • [37] Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors.
    Schreiber, G
    Murphy, E
    Horton, J
    Nass, C
    TRANSFUSION, 1996, 36 (09) : S172 - S172
  • [38] IMPACT OF THE IMPLEMENTATION OF A MODIFIED HTLV-I EIA ON THE DETECTION OF HTLV-I AND HTLV-II ANTIBODIES IN BLOOD-DONORS
    VALINSKY, JE
    RIOS, M
    BIANCO, C
    TRANSFUSION, 1993, 33 (09) : S38 - S38
  • [39] HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS TYPE-I (HTLV-I) ASSOCIATED LEUKEMIAS IN VENEZUELA
    MERINO, F
    DESALVO, L
    MERINOARENDS, A
    GUEVARA, J
    AMESTY, C
    INVESTIGACION CLINICA, 1987, 28 (04): : 197 - 203
  • [40] A CASE-CONTROL STUDY OF RISK-FACTORS FOR INFECTION WITH HUMAN T-LYMPHOTROPIC VIRUSES TYPE-I AND TYPE-II (HTLV-I AND HTLV-II) AMONG US BLOOD-DONORS
    MURPHY, EL
    SCHREIBER, G
    CHIEN, HC
    NASS, C
    GARFEIN, RS
    OWNBY, H
    SMITH, JW
    FRIDEY, J
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (11) : S44 - S44